Everett Neville Sells 617 Shares of Cigna Group (NYSE:CI) Stock

Cigna Group (NYSE:CI) insider Everett Neville sold 617 shares of the company’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the transaction, the insider owned 5,053 shares in the company, valued at $1,435,304.65. This represents a 10.88% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Cigna Group Trading Down 2.3%

CI stock traded down $6.40 during midday trading on Tuesday, hitting $276.12. 1,521,699 shares of the company’s stock were exchanged, compared to its average volume of 1,684,743. Cigna Group has a 1-year low of $239.51 and a 1-year high of $315.47. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $72.96 billion, a PE ratio of 11.42, a P/E/G ratio of 0.97 and a beta of 0.31. The business has a 50-day simple moving average of $283.56 and a two-hundred day simple moving average of $280.94.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. The business had revenue of $70.04 billion during the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The company’s revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the business posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, sell-side analysts predict that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.3%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is 25.82%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Brighton Jones LLC grew its stake in Cigna Group by 9.3% during the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after buying an additional 318 shares during the last quarter. Sivia Capital Partners LLC grew its position in shares of Cigna Group by 10.4% during the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock worth $384,000 after acquiring an additional 109 shares during the last quarter. NewEdge Advisors LLC grew its position in shares of Cigna Group by 4.5% during the second quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock worth $7,347,000 after acquiring an additional 958 shares during the last quarter. Treasurer of the State of North Carolina increased its holdings in shares of Cigna Group by 16.6% in the 2nd quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock valued at $49,204,000 after acquiring an additional 21,173 shares during the period. Finally, Osterweis Capital Management Inc. purchased a new stake in Cigna Group in the 2nd quarter valued at $163,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently commented on CI shares. Jefferies Financial Group lowered Cigna Group from a “buy” rating to a “hold” rating and lowered their price target for the stock from $336.00 to $307.00 in a research report on Tuesday, August 4th. Guggenheim increased their target price on Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. Barclays raised their target price on Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Wells Fargo & Company boosted their price target on shares of Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Finally, Raymond James Financial cut shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and reduced their price target for the stock from $350.00 to $320.00 in a research report on Monday, August 3rd. Fifteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $339.45.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.